Xueyan Cao

Dr. Xueyan Cao

DONGHUA UNIVERSITY
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 February 2018 in Nanomaterials
Verified
Journal Article
Open access
PDF file
JQJieru Qiu
Jieru Qiu
LKLingdan Kong
Lingdan Kong
XCXueyan Cao
Xueyan Cao
ALAijun Li
Aijun Li
PWPing Wei
Ping Wei
Xiangyang ShiXiangyang Shi
Xiangyang Shi
We describe a safe and highly effective non-viral vector system based on β-cyclodextrin (β-CD)-modified dendrimer-entrapped gold nanoparticles (Au DENPs) for improved delivery small interfering RNA (siRNA) to glioblastoma cells. In our approach, we utilized amine-terminated generation 5 poly(amidoamine) dendrimers partially grafted with β-CD as a nanoreactor to entrap Au NPs. The acquired β-CD-modified Au DENPs (Au DENPs-β-CD) were complexed with two different types of therapeutic siRNA (B-cell lymphoma/leukemia-2 (Bcl-2) siRNA and vascular endothelial growth factor (VEGF) siRNA). The siRNA compression ability of the Au DENPs-β-CD was evaluated by various methods. The cytocompatibility of the vector/siRNA polyplexes was assessed by viability assay of cells. The siRNA transfection capability of the formed Au DENPs-β-CD vector was evaluated by flow cytometric assay of the cellular uptake of the polyplexes and Western blot assays of the Bcl-2 and VEGF protein expression. Our data reveals that the formed Au DENPs-β-CD carrier enables efficiently delivery of siRNA to glioma cells, has good cytocompatibility once complexed with the siRNA, and enables enhanced gene silencing to inhibit the expression of Bcl-2 and VEGF proteins. The developed Au DENPs-β-CD vector may be used for efficient siRNA delivery to different biosystems for therapeutic purposes.

19 May 2018 in Nanomaterials
Verified
Journal Article
Open access
PDF file
FXFanli Xu
Fanli Xu
MLMengxue Liu
Mengxue Liu
Xin LiXin Li
Xin Li
ZXZhijuan Xiong
Zhijuan Xiong
XCXueyan Cao
Xueyan Cao
RGRUI GUO
RUI GUO
The combination of photothermal therapy (PTT) and photodynamic therapy (PDT) in cancer treatment has attracted much attention in recent years. However, developing highly efficient and targeted therapeutic nanoagents for amplifying PTT and PDT treatments remains challenging. In this work, we developed a novel photothermal and photodynamic therapeutic nanoplatform for treatment of cancer cells overexpressing integrin αvβ3 through the coating of polydopamine (PDA) on indocyanine green (ICG)-loaded laponite (LAP) and then further conjugating polyethylene glycol-arginine-glycine-aspartic acid (PEG-RGD) as targeted agents on the surface. The ICG/LAP–PDA–PEG–RGD (ILPR) nanoparticles (NPs) formed could load ICG with a high encapsulation efficiency of 94.1%, improve the photostability of loaded ICG dramatically via the protection of PDA and LAP, and display excellent colloidal stability and biocompatibility due to the PEGylation. Under near-infrared (NIR) laser irradiation, the ILPR NPs could exert enhanced photothermal conversion reproducibly and generate reactive oxygen species (ROS) efficiently. More importantly, in vitro experiments proved that ILPR NPs could specifically target cancer cells overexpressing integrin αvβ3, enhance cellular uptake due to RGD-mediated targeting, and exert improved photothermal and photodynamic killing efficiency against targeted cells under NIR laser irradiation. Therefore, ILPR may be used as effective therapeutic nanoagents with enhanced photothermal conversion performance and ROS generating ability for targeted PTT and PDT treatment of cancer cells with integrin αvβ3 overexpressed.

9 June 2021 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
YPYucheng Peng
Yucheng Peng
YGYue Gao
Yue Gao
CYChao Yang
Chao Yang
RGRUI GUO
RUI GUO
Xiangyang ShiXiangyang Shi
Xiangyang Shi
XCXueyan Cao
Xueyan Cao

28 February 2023 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
JLJunjie Liu
Junjie Liu
GLGaoming Li
Gaoming Li
HGHonghua Guo
Honghua Guo
CNCheng Ni
Cheng Ni
YGYue Gao
Yue Gao
RGRUI GUO
RUI GUO

14 February 2019 in Nanoscale
Verified
Journal Article
Closed access
PDF file
XHXinxin Hao
Xinxin Hao
BXBei Xu
Bei Xu
HCHuan Chen
Huan Chen
XWXiaomeng Wang
Xiaomeng Wang
JZJiulong Zhang
Jiulong Zhang
XCXueyan Cao
Xueyan Cao
Schematic illustration of AG/PEI-Fe 3 O 4 and stem cell-mediated delivery of nanogels for enhanced breast or glioma tumor MR imaging.

27 April 2020 in Journal of Materials Chemistry B
Verified
Journal Article
Closed access
PDF file
HCHuan Chen
Huan Chen
YFYu Fan
Yu Fan
XHXinxin Hao
Xinxin Hao
CYChao Yang
Chao Yang
YPYucheng Peng
Yucheng Peng
XCXueyan Cao
Xueyan Cao
PEGylated Au DENPs ({(Au 0 ) 25 -G5·NH 2 -mPEG 20 }) are synthesized and used as a novel nonviral vector to deliver CpG to mature BMDCs for the subsequent activation of T cells for adoptive tumor immunotherapy.